< path d="M52.6178 31.3114L44.7476 60.6733L74.1095 68.5435L81.9797 39.1816L52.6178 31.3114Z" fill="#F9C32D"/>

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Cancer Genetics stock in Canada

Own Cancer Genetics shares in just a few minutes.

Avatar
Jing Jun Ma
Updated . What changed?
Fact checked

Cancer Genetics is a biotechnology business based in the US. Cancer Genetics stocks (CGIX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Cancer Genetics employs 110 staff and has a trailing 12-month revenue of around $6.3 million.

How to buy stocks in Cancer Genetics

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CGIX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

What's in this guide?

  1. Can I buy shares in Cancer Genetics?
  2. Cancer Genetics shares summary
  3. Compare share dealing platforms
  4. Is Cancer Genetics stock a buy or sell?
  5. Cancer Genetics's financials
  6. How volatile are Cancer Genetics shares?
  7. Does Cancer Genetics pay a dividend?
  8. Have Cancer Genetics shares ever split?
  9. Other common questions

Cancer Genetics stock price (NASDAQ:CGIX)

Use our graph to track the performance of CGIX stocks over time.

Cancer Genetics shares at a glance

Information last updated 2021-05-23.
52-week range$0.00 - $0.00
50-day moving average $5.82
200-day moving average $3.97
Wall St. target price$3.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.52

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
CIBC Investor's Edge
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Go to site
More Info
Wealthsimple Trade
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Go to site
More Info
Scotia iTRADE
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Go to site
More Info
Interactive Brokers
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Go to site
More Info
Questrade
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Go to site
More Info
Qtrade Direct Investing
OFFER
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get $500 in commission free trades when you fund your account with a minimum of $10,000. Conditions apply. Ends August 31st, 2022.
Go to site
More Info
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Cancer Genetics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Cancer Genetics financials

Revenue TTM $6.3 million
Gross profit TTM $3.6 million
Return on assets TTM -14.9%
Return on equity TTM -68.71%
Profit margin -71.5%
Book value $1.92
Market capitalisation $48.7 million

TTM: trailing 12 months

Cancer Genetics share dividends

We're not expecting Cancer Genetics to pay a dividend over the next 12 months.

Have Cancer Genetics's shares ever split?

Cancer Genetics's shares were split on a 1:30 basis on 25 October 2019. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cancer Genetics shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Cancer Genetics shares which in turn could have impacted Cancer Genetics's share price.

Cancer Genetics share price volatility

Over the last 12 months, Cancer Genetics's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cancer Genetics's is 2.7237. This would suggest that Cancer Genetics's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Cancer Genetics overview

Cancer Genetics, Inc. , through its subsidiary, vivoPharm, Pty Ltd. , provides contract research services primarily focusing on studies to guide drug discovery and development programs in the oncology and immuno-oncology fields. The company's clinical offerings include a portfolio of proprietary tests, such as comparative genomic hybridization microarrays and next generation sequencing panels, gene expression tests, and DNA fluorescent in situ hybridization probes targeting hematological, and human papillomavirus-associated cancers, which include cervical, anal, head, and neck cancers. It serves the biotechnology and pharmaceutical customers in the United States, Europe, and Australia. Cancer Genetics, Inc. was founded in 1999 and is headquartered in Rutherford, New Jersey.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site